Erlandsson, Lena
Ohlsson, Lena
Masoumi, Zahra
Rehnström, Mimmi
Cronqvist, Tina
Edvinsson, Lars
Hansson, Stefan R.
Funding for this research was provided by:
Vetenskapsrådet (314373.35.135949)
Swedish SUS Foundations
Hjärt-Lungfonden (20220286)
Swedish ALF grant
Region Skåne
Lund University
Article History
Received: 18 July 2023
Accepted: 24 October 2023
First Online: 27 October 2023
Competing interests
: Stefan R. Hansson holds patents related to diagnosis and treatment of PE and is co-founder of Guard Therapeutics International AB (formerly named A1M Pharma AB). All other authors declare no conflicting interests.